Senior Manager-Full-funnel media & EC Analytics at Eli Lilly and Company

Shanghai, Shanghai, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Bachelor Degree and above, with media analytics and eCommerce analytics background
  • Both agency (consulting, market research, media agency, EC ISV, etc.) and leading MNC consumer brands in-house working experience, >10 years
  • Proven skills of stakeholder influence with excellent communication skills across matrix organizations
  • Language proficiency both in English and Chinese
  • Expert level knowledge of EC (Alibaba/JD) and Digital Media (Tencent/Red/Bytedance), and search (Baidu/GEO) platform data tools and analytics methodology
  • Experience delivering insights that inform critical business decisions

Responsibilities

  • Support BI&A leader to 0-1 build eCommerce analytics & data capability for Lilly China, quick onboarding high-quality deliverables with business impact, and build strategic full-funnel close-loop media and eCommerce analytics framework
  • Support to deliver EC full funnel diagnosis as key business/brand/A&P effectiveness and efficiency excellence enablers, for stakeholders (CMO, Finance, Consumer & Ecommerce leaders, etc.) with insight & opportunity & watch outs
  • Lead media and eCommerce platform data integration and automation, to support business agile decision making and timely actions
  • Collaborate with digital & tech to create faster, smarter AI-enabled analytics solutions that tackle eCommerce business pain-points (competitor surveillance, price elasticity monitoring, etc.)
  • Continuously bring in external best practices and strategic moves from leading players in the industry or winners from other industries
  • Drive cross-functional teams to implement data strategies, establishing an "analysis-decision-execution" closed loop
  • Efficiently manage EC data product development cycles to ensure deep alignment between analytical tools and business needs

Skills

eCommerce Analytics
Full-Funnel Media
BI&A
Data Integration
Automation
AI-Enabled Analytics
Alibaba
JD
Tencent
Red
Bytedance
Baidu
Competitor Surveillance
Price Elasticity
Digital Analytics
Cross-Functional Leadership

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI